A Possible Association Between Thyroid Cancer and Breast Cancer
Authors:
- 1 December 2015
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 25 (12) , 1330-1338
Abstract
Background: Several lines of evidence suggest that breast cancer (BC) and thyroid cancer (TC) occur together in the same female patients more frequently than would be expected by chance. This study investigated the prevalence and clinicopathological characteristics of second primary BC in TC patients and second primary TC in BC patients. Methods: A retrospective case-controlled study was performed in 4243 patients with differentiated TC and 6833 patients with BC. Age-matched control groups without second malignancies were selected. Results: Of the 4243 patients with TC, 55 patients developed subsequent BC during a five-year follow-up (range 2–40 years); the standardized incidence ratio (SIR) was 2.45 [confidence interval (CI) 1.83–2.96]. Among the 6833 patients with BC, 81 patients developed subsequent TC during a 6.2-year follow-up (range 2–40 years); the SIR was 2.18 [CI 1.43–2.82]. Subsequent second BC or TC diagnosed within five years of the initial primary malignancy showed more clinical characteristics consistent with early-stage cancer than did control BC or TC patients. Notably, the expression of both the estrogen and progesterone receptors was significantly higher in the tissues of BC patients with coexisting TC compared with those with BC alone. Conclusions: The overall risk of second primary TC or BC is increased in patients with prior BC or TC, respectively. The early detection of second cancer might have contributed to these findings. However, BC that coexisted with TC had a higher expression of hormone receptors, suggesting an association between the molecular pathogenesis of TC and BC.Keywords
This publication has 26 references indexed in Scilit:
- Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancerWorld Journal of Surgical Oncology, 2011
- Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysisThyroid®, 2009
- Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapyBreast Cancer Research and Treatment, 2008
- Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-AnalysisThyroid®, 2007
- Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancerBMC Cancer, 2007
- RETRACTED: 17β-Estradiol, Genistein, and 4-Hydroxytamoxifen Induce the Proliferation of Thyroid Cancer Cells through the G Protein-Coupled Receptor GPR30Molecular Pharmacology, 2006
- Risk of Second Primary Malignancies in Women with Papillary Thyroid CancerAmerican Journal of Epidemiology, 2006
- The risk of multiple primary breast and thyroid carcinomasCancer, 2003
- Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular MechanismsThe Journal of Clinical Endocrinology & Metabolism, 2001
- Second Primary Cancers Following Breast Cancer in the Japanese Female PopulationJapanese Journal of Cancer Research, 2001